Literature DB >> 2866524

Myc oncogene activation in B and T lymphoid tumours.

J M Adams, S Cory.   

Abstract

The chromosome translocations characteristic of certain B lymphoid tumours associate the myc oncogene and immunoglobulin loci. The typical t(12;15) in murine plasmacytomas and analogous t(14;8) in Burkitt lymphomas couple the myc coding region to one of the switch recombination regions within the immunoglobulin heavy (H) chain locus; hence the switch machinery may promote some translocations. Significantly, translocation induces constitutive myc expression, the untranslocated myc allele remaining silent. The predilection for breakpoints near the 5' end of the c-myc gene may reflect selection for altered myc regulation. In most tumours, the stimulatory effect of the H locus context is not understood, but an H locus enhancer participates in some tumours, including one displaying a novel transposition. The variant (6;15) translocations found in about 15% of plasmacytomas involve the myc band and the region of chromosome 6 where the kappa locus lies. The t(6;15) is shown here to represent an exchange between C kappa and a chromosome 15 locus (designated pvt-1) which lies unexpectedly far from c-myc. The association of myc expression with pvt-1 alterations suggest that myc can be activated at a distance. Myc has also been implicated in some T lymphomas by detection of proviral inserts near myc and also, surprisingly, within the pvt-1 locus. Inserts near myc appear to activate its expression via the retroviral enhancer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866524     DOI: 10.1098/rspb.1985.0079

Source DB:  PubMed          Journal:  Proc R Soc Lond B Biol Sci        ISSN: 0950-1193


  7 in total

1.  Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.

Authors:  Sandrine Sander; Dinis P Calado; Lakshmi Srinivasan; Karl Köchert; Baochun Zhang; Maciej Rosolowski; Scott J Rodig; Karlheinz Holzmann; Stephan Stilgenbauer; Reiner Siebert; Lars Bullinger; Klaus Rajewsky
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

2.  Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.

Authors:  Lina Happo; Mark S Cragg; Belinda Phipson; Jon M Haga; Elisa S Jansen; Marco J Herold; Grant Dewson; Ewa M Michalak; Cassandra J Vandenberg; Gordon K Smyth; Andreas Strasser; Suzanne Cory; Clare L Scott
Journal:  Blood       Date:  2010-09-09       Impact factor: 22.113

Review 3.  Genetic Modeling of PIM Proteins in Cancer: Proviral Tagging and Cooperation with Oncogenes, Tumor Suppressor Genes, and Carcinogens.

Authors:  Enara Aguirre; Oliver Renner; Maja Narlik-Grassow; Carmen Blanco-Aparicio
Journal:  Front Oncol       Date:  2014-05-15       Impact factor: 6.244

Review 4.  The Role of Caspase-2 in Regulating Cell Fate.

Authors:  Vasanthy Vigneswara; Zubair Ahmed
Journal:  Cells       Date:  2020-05-19       Impact factor: 6.600

5.  Stress-induced cleavage of Myc promotes cancer cell survival.

Authors:  Maralice Conacci-Sorrell; Celine Ngouenet; Sarah Anderson; Thomas Brabletz; Robert N Eisenman
Journal:  Genes Dev       Date:  2014-04-01       Impact factor: 11.361

6.  Recombinase-based conditional and reversible gene regulation via XTR alleles.

Authors:  Camila Robles-Oteiza; Sarah Taylor; Travis Yates; Michelle Cicchini; Brian Lauderback; Christopher R Cashman; Aurora A Burds; Monte M Winslow; Tyler Jacks; David M Feldser
Journal:  Nat Commun       Date:  2015-11-05       Impact factor: 14.919

Review 7.  Beyond the RNA-dependent function of LncRNA genes.

Authors:  Tamer Ali; Phillip Grote
Journal:  Elife       Date:  2020-10-23       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.